Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-04 8:17 pm Purchase | 2026-07-28 | 13G | ENTERA BIO LTD SHS ENTX | Longitude Capital Partners V, LLC | 7,843,138 4.600% | 7,843,138 (New Position) | Filing History |
| 2026-08-04 7:10 pm Purchase | 2026-07-28 | 13G | ENTERA BIO LTD SHS ENTX | Seven Fleet Capital Management LP | 7,053,898 4.100% | 7,053,898 (New Position) | Filing History |
| 2026-08-04 7:07 pm Purchase | 2026-07-28 | 13D | ENTERA BIO LTD SHS ENTX | BIOTECHNOLOGY VALUE FUND L P | 17,225,121 9.990% | 17,225,121 (New Position) | Filing History |
| 2026-08-04 4:24 pm Purchase | 2026-07-28 | 13G | ENTERA BIO LTD SHS ENTX | TCG Crossover GP III, LLC | 12,254,901 7.100% | 12,254,901 (New Position) | Filing History |
| 2026-08-04 2:48 pm Purchase | 2026-07-28 | 13G | ENTERA BIO LTD SHS ENTX | Vivo Opportunity Fund Holdings, L.P. | 11,817,401 6.900% | 11,817,401 (New Position) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | ENTERA BIO LTD SHS ENTX | Point72 Asset Management, L.P. | 1,183,116 2.600% | -1,518,444 (-56.21%) | Filing History |
| 2025-04-02 6:51 pm Purchase | 2025-03-16 | 13G | ENTERA BIO LTD SHS ENTX | OPKO HEALTH, INC. OPK | 3,685,226 8.100% | 3,685,226 (New Position) | Filing History |
| 2025-01-06 4:10 pm Purchase | 2025-01-03 | 13G | ENTERA BIO LTD SHS ENTX | Point72 Asset Management, L.P. | 2,701,560 6.800% | 2,701,560 (New Position) | Filing History |
| 2024-11-20 1:48 pm Purchase | 2024-11-14 | 13G | ENTERA BIO LTD SHS ENTX | Knoll Capital Management LLC | 5,881,879 15.000% | 2,000,000 (+51.52%) | Filing History |
| 2024-08-20 06:01 am Unchanged | 2024-07-19 | 13G | ENTERA BIO LTD SHS ENTX | CENTILLION FUND INC. | 2,396,953 6.700% | 0 (Unchanged) | Filing History |
| 2024-01-16 10:45 am Purchase | 2023-12-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Knoll Capital Management LLC | 3,881,879 9.967% | 3,799,070 (+4587.75%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ENTERA BIO LTD SHS ENTX | RA Capital Management, L.P. | 295,966 1.000% | -2,057,034 (-87.42%) | Filing History |
| 2022-11-18 12:40 pm Purchase | 2022-08-31 | 13G | ENTERA BIO LTD SHS ENTX | CENTILLION FUND INC. | 2,396,953 8.320% | 1,131,130 (+89.36%) | Filing History |
| 2022-11-17 6:36 pm Unchanged | 2022-08-31 | 13G | ENTERA BIO LTD SHS ENTX | CENTILLION FUND INC. | 1,265,823 4.390% | 0 (Unchanged) | Filing History |
| 2022-11-17 6:34 pm Purchase | 2022-08-31 | 13G | ENTERA BIO LTD SHS ENTX | CENTILLION FUND INC. | 1,265,823 4.390% | 134,693 (+11.91%) | Filing History |
| 2022-11-10 5:25 pm Unchanged | 2021-12-31 | 13G | ENTERA BIO LTD SHS ENTX | CENTILLION FUND INC. | 1,131,130 3.930% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:30 am Sale | 2021-12-31 | 13G | ENTERA BIO LTD SHS ENTX | Capital Point Ltd. | 0 0.000% | -1,147,385 (Position Closed) | Filing History |